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Wai Mun Loke1, Angelia Yee Chow2, Karen Lam Mok Sing1, Chung-Yung J Lee1,3, Barry Halliwell3, Erle CH Lim1,
Amy ML Quek1, Eng Eong Ooi2 and Raymond CS Seet1*Abstract
Background: Leukotriene B4, a 5-lipoxygenase product of arachidonic acid with potent chemotactic effects on
neutrophils, has not been assessed in dengue patients. In this study, plasma leukotriene B4 and serum high-
sensitivity C-reactive protein levels were determined in adult patients during the febrile, convalescent and
defervescent stages of dengue serotype-2 (DENV-2) infection, and compared with those of age--matched healthy
and non-dengue febrile subjects. In vitro studies were performed to examine the effects of live and heat-inactivated
DENV-2 on the activities and expression of 5-lipoxygenase in human neutrophils.
Results: Plasma leukotriene B4 was elevated during the febrile stages of dengue infection compared to levels
during convalescence and in study controls. Plasma leukotriene B4 also correlated with serum high-sensitivity
C-reactive protein in dengue patients (febrile, r = 0.91, p < 0.001; defervescence, r = 0.87, p < 0.001; convalescence,
r = 0.87, p < 0.001). Exposure of human neutrophils to DENV-2 resulted in a significant rise in leukotriene B4; the
extent of increase, however, did not differ between exposure to live and heat-inactivated DENV-2. Pre-incubation
of either live or heat-inactivated DENV-2 resulted in reduced leukotriene B4 release by neutrophils, indicating that
contact with dengue antigens (and not replication) triggers the neutrophil response. Production of leukotriene B4
was associated with an increase in 5-lipoxygenase expression in human neutrophils; addition of MK886 (a 5-
lipoxygenase activating protein inhibitor) attenuated further increase in leukotriene B4 production.
Conclusion: These findings provide important clinical and mechanistic data on the involvement of 5-lipoxygenase
and its metabolites in dengue infection. Further studies are needed to elucidate the therapeutic implications of
these findings.
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Dengue is an important infectious cause of morbidity in
tropical and subtropical countries. It is estimated that
250,000 cases of severe dengue infections and at least
100 million cases of dengue fever occur annually [1,2].
Following an initial infection by dengue virus that is
transmitted primarily by the Aedes aegypti mosquito,
high fever develops in the first 2–7 days (febrile stage)
where viral replication takes place [1]. Thereafter, fever
ceases (defervescent stage) and within 2 days, viremia
falls to undetectable levels and clinical recovery to health
begins (convalescent stage) [1,3]. Rapid onset of infla-* Correspondence: raymond_seet@nus.edu.sg
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stated.mmation and activation of effective cellular immune re-
sponses limit the spread of virus during the initial stages
of infection [1,3]. Among the effector cells playing a role
in the inflammatory and immune responses are the poly-
morphonuclear leukocytes [4,5].
Neutrophils, the most abundant circulating poly-
morphonuclear leukocytes, are the first cell type to mi-
grate from blood vessels before reaching infectious loci
within the peripheral tissues. Neutrophils play a pivotal
role in the phagocytosis of particles, production of react-
ive oxygen species (O2-, HOCl and H2O2), lipid me-
diators (such as leukotrienes, prostaglandins, lipoxins
and platelet-activating factors) and secretion of anti-
microbial proteins [6,7]. One such well-characterized
proinflammatory lipid mediator produced by neutrophils
is leukotriene B4 (LTB4), a tetraunsaturated 20-carbond. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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lipoxygenase and leukotriene A4 hydrolases on arachi-
donic acid [8]. LTB4 is involved in several inflammatory
diseases (such as myocardial infarction and stroke) [9]
and is capable of inducing antimicrobial responses [10].
By modulating cell surface G protein-coupled receptors
(BLT1 and BLT2) [11], LTB4 promotes migration of neu-
trophils, monocytes and macrophages to sites of inflam-
mation [12]. The level of C-reactive protein (CRP) is
higher in diseases in which inflammation is implicated
[3,13,14]. Greater levels of CRP have been observed
among dengue patients compared with age-matched non-
dengue controls [3,15] and among those with greater den-
gue severity [15].
To assess the relevance of the 5-lipoxygenase pathway
in the pathogenesis of dengue infection, plasma LTB4
and serum high-sensitivity C-reactive protein (hsCRP)
were measured in a cohort of patients with acute dengue
virus serotype-2 (DENV-2) infection and age-matched
controls. To determine their temporal changes, these
markers were assessed during the different clinical stages
of dengue infection (febrile, defervescence and convales-
cence). In vitro studies were performed to examine the
effects of live and heat-inactivated DENV-2 on activities
and expression of 5-lipoxygenase in human neutrophils.
Results
Plasma LTB4 was significantly elevated during the febrile
and defervescent stages of dengue infection compared
with healthy and non-dengue febrile controls (p < 0.05,
Table 1). These levels decreased further, approaching those
of healthy controls and during convalescence (p < 0.001,
Table 1). Serum hsCRP concentrations were higher in pa-
tients with DENV-2, especially during the febrile stage of
dengue illness (Table 1). No significant difference was ob-
served during disease convalescence and healthy controls
for both plasma LTB4 and serum hsCRP (Table 1). Plasma
LTB4 and serum hsCRP in non-dengue febrile controls
were also significantly higher compared with healthy con-
trols (p < 0.05, Table 1). Plasma arachidonic acid (AA) and
PLA2 activities were not altered throughout the different
stages of DENV-2 infection (Table 1).Table 1 Circulating concentrations (mean ± SD) of measured p
infection during the febrile stage, defervescence and convale
non-dengue febrile controls (N = 15)
Parameters Febrile Defervescen
Plasma LTB4 (pmol/μmol AA) 0.35 (0.35)b 0.38 (0.34)b
Serum hsCRP (mg/L) 6.10 (6.70)b 3.30 (3.00)b
Plasma arachidonic acid (μg/mL) 89.0 (26.4)a 95.8 (24.3)a
Plasma phospholipase A2 activity (nmol/ min/mL) 4.3 (0.9)
a 4.4 (1.0)a
Data are summarized as mean (standard deviation).
aNormally distributed data with the same subscripts are not significantly different w
b,c,dNon-parametric data with the same subscripts are not significantly different witPlasma LTB4 correlated significantly with serum hsCRP
in patients with DENV-2 during the different stages of in-
fection (febrile, r = 0.91, p < 0.001; defervescent, r = 0.87,
p < 0.001; convalescent, r = 0.87, p < 0.001). A reduction in
plasma LTB4 between the febrile and convalescent stages of
illness also correlated with the changes in serum hsCRP
concentration (r = 0.86, p < 0.001). These associations, how-
ever, were not observed in non-dengue febrile controls.
The effects of exposure to live and heat-inactivated
DENV-2 on the 5-lipoxygenase pathway were examined
using freshly isolated peripheral neutrophils. These neu-
trophils were incubated with or without DENV-2 at a
multiplicity of infection of 1 over a period of 7 hours be-
fore these were stimulated with calcium ionophore
A23187. In the absence of exogenous AA, no difference
in LTB4 production in neutrophils was observed. Exogen-
ous AA was added to the incubation medium to eliminate
the potential confounding effects of phospholipase A2
(PLA2) and to examine the consequences of DENV-2 on
5-lipoxygenase in human neutrophils. Figure 1A shows
production of LTB4 by freshly isolated neutrophils treated
with DENV-2 during an incubation period of 7 hours. Re-
lease of LTB4 from human neutrophils exposed to DENV-2
was maximal five hours following incubation, before reach-
ing a plateau. By contrast, neutrophils that were not exposed
to DENV-2 did not produce detectable amounts of LTB4.
As expected, production of LTB4 from human neutro-
phils was suppressed by MK886 (a 5-lipoxygenase activat-
ing protein inhibitor) (Figure 1B). Neutrophils incubated
with DENV-2 alone produced comparable amounts of
LTB4 as those stimulated with A23187. There were no dif-
ferences in production of LTB4 by neutrophils treated with
live or heat-inactivated DENV-2 (Figures 1A and 1B), sug-
gesting that DENV-2 infectivity is not a pre-requisite for
LTB4 production. Neutrophils treated with both DENV-2
and A23187 produced significantly higher amounts of
LTB4 than those treated with either the virus or A23187 (p
< 0.05 vs A23187 stimulated neutrophils, Figure 1B).
Addition of MK886 attenuated the production of LTB4 in
the presence of DENV-2.
Representative 5-lipoxygenase and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) Western blots per-arameters in patients with dengue serotype-2 virus
scence (N = 15), in healthy controls (N = 20) and in
ce Convalescence Healthy controls Non-dengue febrile controls
0.01 (0.02)c 0.01 (0.01)c 0.17 (0.12)d
0.60 (1.50)c 1.02 (1.01)c 3.36 (3.69)b
110.0 (20.2)a 86.5 (19.7)a 87.7 (22.5)a
4.2 (0.9)a 4.2 (1.1)a -
ith each other using one-way ANOVA analyses with Bonferroni adjustment.
h each other using Kruskal-Wallis analysis with Dunn’s adjustment.
Figure 1 Production of leukotriene B4 by neutrophils incubated with or without DENV-2. (A) Production of leukotriene B4 (ng/10
6 cells) by
freshly isolated peripheral neutrophils over 7-hour incubation in the presence and absence of live dengue viruses exposure (DENV-2), heat-inactivated
dengue viruses exposure (hiDENV-2), and A23187 (A) treatment (N = 5). * p< 0.05 vs untreated cells using one-way ANOVA analysis of the area under the
curves with Bonferroni adjustments. (B) Leukotriene B4 production (ng/10
6 cells) from freshly isolated peripheral neutrophils after 5 hours of incubation
with or without live dengue viruses exposure (DENV-2), heat-inactivated dengue viruses exposure (hiDENV-2), MK886 (MK) and A23187 (A) treatment
(N = 5). Bars with the same subscripts are not significantly different from each other using one-way ANOVA analysis with Bonferroni adjustments.
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DENV-2 are shown in Figure 2A. The levels of 5-
lipoxygenase protein in neutrophils were significantly
higher after incubation with DENV-2 (p < 0.05 vs un-
treated cells, Figure 2B). Introduction of MK886 did not
influence the expression of 5-lipoxygenase protein in
neutrophils exposed to DENV-2 (data not shown). Fol-
lowing incubation of neutrophils with DENV-2, the
amount of LTB4 produced correlated significantly with
the expression of 5-lipoxygenase protein in neutrophils
at 0 and 7 hour time-points (r = 0.54, p < 0.05 at time
0 hour; r = 0.65, p < 0.05 at time 7 hour), but not at
2.5 hour. Despite prolonged incubation for 72-hours of
DENV-2 in neutrophil suspension, immunofluorescence
assays did not detect the presence of DENV-2 in neutro-
phils, indicating the inability of DENV-2 to infectneutrophils in vitro (data not shown). Furthermore,
addition of anti-DENV-2 antibody to neutrophils inhib-
ited LTB4 production compared to neutrophils exposed
to live DENV-2 and hiDENV-2 without anti-dengue
antibody (Figure 3). These findings collectively suggest
that exposure to DENV but not viral replication in neu-
trophil triggers LTB4 production.
Discussion
Previous studies have implicated 5-lipoxygenase and
LTB4 in the pathogenesis of various microbial diseases
[16,17]. An interaction between the Epstein-Barr virus
and monocytes is thought to upregulate LTB4 formation
by enhancing 5-lipoxygenase and phospholipase activ-
ities [18]. Another study observed greater expressions of
5-lipoxygenase and LTB4 in vascular smooth muscle
Figure 2 5-Lipoxygenase expression by neutrophils incubated with or without dengue viruses. The proteins were isolated from
neutrophils and were electrophoretically transferred from the gel onto Hybond-C Extranitrocellulose membrane. The membrane was then cut,
based on the size of proteins of interest, to separate the 5-lipoxygenase (79 kDa) and the control protein GAPDH (39 kDa). (A) Representative
films from 5-lipoxygenase and GAPDH Western blots performed with untreated neutrophils and neutrophils incubated with live (DENV-2) or heat-
inactivated dengue viruses (hiDENV-2). (B) Expression of 5-lipoxygenase protein by untreated neutrophils (×) and neutrophils exposed to live
(DENV-2, □) or heat-inactivated dengue viruses (hiDENV-2, ■) (N = 3). * p < 0.05 vs untreated cells using one-way ANOVA analysis of the area
under the curves with Bonferroni adjustments.
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Addition of human immunodeficiency virus-1 envelope
proteins stimulates release of arachidonic acid-derived
5-lipoxygenase products (such as LTB4 and LTC4), from
human mononuclear cells via signalling through the
CD4 molecules (T-helper immune cells) [20]. In pneu-
monia patients, an increase in LTC4 in the respiratory
tract secretion is associated with the presence of respira-
tory syncytial virus [21]. A detailed understanding on
the roles of lipoxygenases in dengue infection is neces-
sary as emerging data are beginning to suggest that leu-
kotrienes produced during an infection may exert
antimicrobial activities. In healthy subjects, nasal admin-
istration of LTB4 increases nasal neutrophil recruitmentand activity [22] while, in vitro, HIV viral replication is
significantly reduced after LTB4 administration [23].
In the current study, DENV-2 infection was shown to
increase the levels of circulatory LTB4 as compared with
age-matched controls, and the rise was apparent even
when comparisons were made with patients with febrile
illnesses that were not caused by dengue infection. Fol-
lowing exposure to DENV-2 in vitro, a time-dependant
release of LTB4 was observed before reaching a plateau
approximately five hours following DENV-2 exposure.
The correlation between LTB4 production and 5-
lipoxygenase expression is biologically important as this
suggests that the observed rise in circulatory LTB4 may
(in part) be explained by the release of LTB4 from
Figure 3 Production of leukotriene B4 by neutrophils incubated
with or without anti-DENV-2 antibody. Production of leukotriene
B4 (ng/10
6 cells) from freshly isolated peripheral neutrophils after
5-hour incubation in the presence and absence of anti-DENV-2
antibody (antiDENV), with live DENV-2 (DENV), heat-inactivated
DENV-2 (hiDENV) and A23187 (A) treatment (N = 5). * p < 0.05 vs
DENV + A using one-way ANOVA analysis with Bonferroni
adjustments. # p < 0.05 vs hiDENV + A using one-way ANOVA
analysis with Bonferroni adjustments.
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inactivated DENV-2, we were not able to demonstrate dif-
ferences in the production of LTB4 and expression of 5-
lipoxygenase in neutrophils. Nor was there evidence to in-
dicate the ability of DENV-2 to infect neutrophils and trig-
ger circulatory release of LTB4. Furthermore, the addition
of anti-dengue antibody reduced LTB4 production by neu-
trophils stimulated by either live or hi-DENV-2. Collect-
ively, these findings suggest that viral infectivity and
replication is not a requirement for increased activities of
5-lipoxygenase in dengue infection. Instead, our data are
consistent with an effect on ‘antigen sensing’ although the
exact mechanism for this sensing remains to be deter-
mined. It remains plausible that contact and exposure to
dengue antigens might trigger the release of LTB4 from
neutrophils, either by directly stimulating the 5-
lipoxygenase enzyme or, indirectly, by altering the bio-
chemical milieu and signalling pathways of human neutro-
phils to enhance antigen recognition [24].
It is not known whether the observed elevation in
LTB4 is beneficial or deleterious in dengue infection.
Previous studies suggested that LTB4 may be beneficial
in viral-related events. Although LTB4 is known primar-
ily for its chemotactic affinity towards leukocytes, LTB4
is also capable of activating several functional host de-
fence through secretion of lysosomal enzymes, augmen-
tation of NADPH oxidase activity, nitric oxide and
defensins production, and phagocytosis [6,7]. Morerecent studies indicate that LTB4 may be an important
mediator involved in the control of viral infection by re-
leasing powerful antimicrobial peptides from peripheral
neutrophils [10,25-27]. Over-expression of LTB4 may also
modulate innate immunity responses by activating effector
T cells, which in turn limits the propagation of these vi-
ruses [28,29]. On the other hand, elevated LTB4 may in-
duce a range of cellular and molecular events that
coordinate and amplify inflammatory responses [30], espe-
cially within the vasculature [31]. LTB4 has been shown to
strongly induce monocyte chemoattractant protein-1
(MCP-1) production in human monocytes via activation
of ERK1/2 or JNK MAPK [32]. LTB4 receptor blockade ef-
fectively reduced monocytic foam cell formation and de-
layed the lesion progression in ApoE knockout mice [33].
Limited data are available on the involvement of mono-
cytes and macrophages in response to 5-lipoxygenase de-
rived metabolites during dengue infection. Elevated levels
of hsCRP indicate acute inflammation during the febrile
stage, while normalization of their values during deferves-
cence and convalescence suggests diminution of these in-
flammatory responses following recovery. There is evidence
that neutrophil-derived LTB4 is involved in inflammatory
diseases such as rheumatoid arthritis [34] and atheroscler-
osis [31]. Significant correlations between circulating hsCRP
and LTB4 concentrations during DENV-2 infection suggest
that LTB4 may have important roles in inflammatory events
during DENV-2 infection, and this may explain the extent
of vascular damage that occurs during DENV-2 infection.
Although dengue infection is characterized by an adult
predominance and DENV serotype-2 is the most common
circulating strain in Singapore, results from this study may
not be applicable to younger patients with dengue sero-
types other than serotype-2 and different dengue severities
[2]. Our observation also did not exclude the possible con-
tribution of increased levels or activities of 5-lipoxygenase
activating protein, coactosin-like protein or LTA4 hydro-
lase induced by DENV antigens in neutrophils.
Conclusions
These findings add to the relatively sparse human data on
the relevance of 5-lipoxygenase-related mediators to hu-
man diseases. Coupled with findings from in vitro studies
that showed augmented LTB4 productions from neutro-
phils following exposure to DENV-2, our data support the
ability of DENV to trigger the release of LTB4 from neu-
trophils. These findings call for further studies to assess
the importance of the 5-lipoxygenase in modulating viral
and host defence factors in dengue infection.
Methods
Chemicals
Bovine serum albumin (BSA), calcium chloride, potassium
chloride, calcium ionophore A23187, Hepes, MK886,
Loke et al. Virology Journal 2013, 10:322 Page 6 of 9
http://www.virologyj.com/content/10/1/322sodium phosphate dibasic, sodium bromide, sodium
chloride, sodium hydrogen carbonate, glucose, sodium
phosphate monobasic, dextran 500, protease inhibitor
P8340, Radio Immunoprecipitation Assay buffer (RIPA),
β-mercaptoethanol, glycerol, Tris–HCl, bromophenol
blue, glycine, sodium dodecyl sulfate (SDS), isooct-
ane, methyl-cellulose, penicillin, streptomycin, formalde-
hyde, crystal violet, 2,3,4,5,6-pentafluorobenzylbromide
(PFBBr), N,N-diisopropylethylamine (DIPEA) and N,O-
Bis(trimethylsilyl)trifluoroacetamide in 1% trimethylsilane
(BSTFA +TMS) were purchased from Sigma Aldrich (St
Louis, MO, USA); d8-arachidonic acid (AA-d8) and d4-
LTB4 from Cayman Chemical (Ann Arbor, MI, USA);
acetonitrile, magnesium sulphate and sulfuric acid from
Merck (Darmstadt, Germany); Ficoll-paque plus® from GE
Healthcare (Uppsala, Sweden); phosphate buffered saline
(PBS), Hank’s balanced salt solution (HBSS), fetal calf
serum (FCS), heat-inactivated fetal calf serum (HIFCS)
and RPMI 1640 from Gibco™ Invitrogen (Calsbad, CA,
USA); mouse anti-human 5-LOX antibody from BD Bio-
sciences (San Jose, CA, USA); Hybond-C extranitrocellu-
lose membrane and anti-mouse horseradish peroxidase
(HRP) from Amersham (Buckinghamshire, UK); Vero cells
(ATCC: CCL-81), DENV-2 specific monoclonal antibody
3H5 (ATCC: HB46) and BHK-21 cells (ATCC: CCL-10)
from American Type Culture Collection (Manassas, VA,
USA); FITC-tagged secondary antibody from Meridian
Life Science® Inc (Saco, ME, USA); mouse anti-human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body from Novus Biological (Littleton, CO, USA); and
methanol and ethanol from Tedia (Fairfield, OH, USA).
Study participants
Adult patients, above the age of 21 with acute DENV
serotype-2 infection (confirmed using RT-PCR), were in-
cluded in this study. Two groups of age- and gender-
matched healthy and non-dengue febrile subjects served
as study controls. Non-dengue febrile controls were se-
lected from patients who presented with acute febrile ill-
ness who were tested negative for DENV using RT-PCR
and did not manifest a four-fold increase in DENV IgG
three months following their acute febrile illness. Clin-
ical information (including age, gender and stage of ill-
ness) was obtained and blood samples were collected
during the febrile, defervescent and convalescent stages
of infection. The study protocol was reviewed and ap-
proved by the Domain-Specific Review Board, National
Healthcare Group, Singapore, and each patient provided
written informed consent prior to study involvement.
The demographics of DENV-infected (n = 14, mean age,
44 years; 40% men), healthy (n = 20, mean age, 43; 55%
men) and non-dengue controls (n = 15, mean age, 42;
55% men) groups were comparable. The mean duration
of symptoms for dengue patients during the febrile stagewas 3 days; defervescence, 6 days; and convalescence,
25 days. Similarly, the mean duration of symptoms for
non-dengue febrile controls was 3 days.
Leukotriene B4 and arachidonic acid measurements
Blood samples collected in EDTA tubes were centrifuged
to obtain plasma, which was stored at −80°C until ana-
lysis. Circulating LTB4 and AA were determined in
plasma using isotope-labelled gas chromatography-mass
spectroscopy (GC-MS) as described previously [35,36].
LTB4 was quantified using a calibration curve obtained
by adding a constant amount of d4-LTB4 (5 ng) to LTB4
(0 to 5000 pg) followed by solvent extraction and deriva-
tization as described previously [35]. Circulating LTB4
concentrations were expressed per unit AA.
High-sensitivity C-reactive protein and phospholipase
activities
Blood samples collected in coagulant-free tubes were
centrifuged to obtain sera. High-sensitivity C-reactive
protein (hsCRP) was measured in serum using Cobas
c111 Photometric Analyzer (Roche Diagnostic GmbH,
Mannheim, Germany). Commercial assay kits were used
to determine plasma phospholipase A2 (PLA2) activities
(Cayman Chemicals, Ann Harbour, MI, USA).
Peripheral neutrophil isolation
Neutrophils were isolated from neutrophil/erythrocyte
pellet from Ficoll-Paque gradient by dextran sedimenta-
tion of red cells as described previously [37]. Cell viabil-
ity was assessed using trypan blue exclusion and was
typically >98%.
Virus preparation
DENV-2 (ST) virus used in this study was a clinical iso-
late obtained from the Singapore General Hospital,
Singapore. These viruses were propagated in Vero cells
(ATCC: CCL-81) and harvested when at least 75% of cell
monolayer showed cytopathic effects. Confirmation of
serotype was performed using immunofluorescence mi-
croscopy on the cell monolayer with serotype-specific
monoclonal antibody (ATCC: HB46). The culture super-
natant was clarified through centrifugation, aliquoted
and stored at −80°C until use. The titer of the culture
supernatant was determined by plaque assay, where ser-
ial 10-fold dilutions of the culture supernatant were
added to BHK-21 cells (ATCC: CCL-10) in 24 well plates
and incubated for 1 hour at 37°C. The inoculum was as-
pirated and replaced with 0.8% methyl-cellulose in main-
tenance medium (RPMI-1640, 2% FCS, 25 mM Hepes,
penicillin and streptomycin). After incubation for 5 days
at 37°C, the cells were fixed with 20% formaldehyde at
room temperature for 20 min. These cells were next
treated with 1% crystal violet for 20 minutes. The
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per mL (pfu/mL) were calculated.
In vitro studies
Freshly isolated neutrophils were resuspended in HBS con-
taining AA (final concentration of 100 μg/ mL) and HBHS
[CaCl2.2H2O (0.18 g/L), glucose (1.0 g/L), Hepes (0.12 g/L),
KCl (0.40 g/L), KH2PO4 (0.06 g/L), MgSO4.7H2O (0.20 g/L),
NaHCO3 (0.36 g/L), NaCl (4.00 g/L), Na2HPO4 (0.04 g/L)
and BSA (1.0 g/L) in pure water; pH 7.4] at a concentration
of 1 × 106 cells/mL. To assess the effect of viral infectivity on
LTB4 production, neutrophils were pre-incubated with live
and heat-inactivated DENV-2 (106 pfu/mL final concentra-
tion). The cell suspension (1 mL) was preincubated with live
and heat-inactivated DENV-2 (106 pfu/mL final concentra-
tion) at 37°C for 0, 0.5, 2.5, 5 and 7 hours prior to 5-
lipoxygenase stimulation. DENV-2 was added using RPMI
1640 as vehicle. The cells were then stimulated with calcium
ionophore A23187 (2.5 μg/mL final concentration) at 37°C
for 15 minutes. Calcium ionopohore induces neutrophil de-
granulation and thereby promotes the release of LTB4 from
neutrophils [38]. The supernatant from cell suspension was
collected and stored at −80°C before LTB4 extraction and
analysis. The cell pellet was resuspended in HBSS and stored
at −80°C before 5-lipoxygenase protein measurement. Un-
treated cells with RPMI 1640 only were used as positive
controls while untreated cells incubated with the leukotriene
biosynthesis inhibitor MK886 (300 nM) [39] served as nega-
tive controls. The release of LTB4 from stimulated neutro-
phils was measured by high performance liquid
chromatography coupled with ultra-violet detection [37].
The ability of DENV-2 to infect neutrophils was exam-
ined by indirect immunofluorescence assay using DENV
serotype 2-specific antibody (ATCC:HB46) and FITC-
tagged secondary antibody. The neutrophil suspension
(1 mL in HBHS) was preincubated with live DENV-2
(106 pfu/ mL final concentration) at 37°C for 48 and
72 hours prior to infectivity assay. Cell viability was con-
firmed as at least 80% at the end of incubation using try-
pan blue exclusion.
A separate experiment was conducted to investigate
whether anti-DENV-2 antibody would affect the production
of LTB4 in human neutrophils. Anti-DENV-2 antibody
(ATCC:HB46) was incubated for 5 hours with neutrophils
treated with live and heat-inactivated DENV-2. At the end
of incubation, the cells were stimulated with calcium iono-
phore and LTB4 production was measured as described
above. The amount of LTB4 production in neutrophils that
were incubated with and without anti-DENV-2 antibodies
was subsequently compared.
Western blot analysis
5-Lipoxygenase expression was determined in freshly iso-
lated neutrophils at 0, 2.5 and 7 hours after incubationwith DENV using electrophoresis on SDS gel and subse-
quent Western blot analysis. Proteins were isolated by sus-
pending neutrophils in RIPA buffer containing protease
inhibitor P8340 (20 μL/ mL of RIPA-buffer) for 30 minutes
on ice. Protein sample (20 μL) was mixed with 5X sample
buffer (10% SDS, 10 mM β-mercaptoethanol, 20% gly-
cerol, 0.2 M Tris–HCl pH 6.8, 0.05% bromophenol blue)
and allowed to denature in boiling water for 5 minutes.
After centrifugation at 10,000 rpm at room temperature,
the supernatant was loaded on 10% SDS-gel. Gel electro-
phoresis was run at a constant voltage of 120 V, for about
2 hours, or until bromophenol blue front reached the bot-
tom of the gel. The proteins were electrophoretically
transferred from the gel onto Hybond-C Extranitrocellu-
lose membrane in a transfer buffer containing 25 mM of
Tris–HCl, 192 mM of glycine and 20% methanol at a
transfer voltage of 100 V over 90 minutes. The membrane
was then cut, based on the size of proteins of interest, to
separate the 5-lipoxygenase (79 kDa) and the control pro-
tein GAPDH (39 kDa). They were blocked separately over-
night in TBS-T buffer (Tris-buffered saline with 1%
Tween-20), containing 5% milk, at 4°C or in cold room,
with gentle shaking. The blocked membranes were incu-
bated in fresh TBS-T buffer, containing 5% milk and
mouse anti-human 5-lipoxygenase (1:1000 vol/vol) or
mouse anti-human GAPDH (1:5000 vol/vol) for 1 hour at
room temperature. After incubation, the membranes were
washed 4 times with TBS-T buffer, before they were
treated with anti-mouse HRP secondary antibody (1:5000
vol/vol) for 1 hour at room temperature. After washing
with TBS-T buffer, the membranes were realigned on the
film cassette, and 5-lipoxygenase and GAPDH proteins
were visualized with an ECL Western blot analysis system
(Amersham, UK) and exposed to radiofilm (Amersham,
UK). The intensity of the protein band on exposed film
was measured using ImageJ software (NIH, USA). 5-
lipoxygenase protein expression was expressed as the ratio
of 5-lipoxygenase protein band intensity to those of
GAPDH within the same membrane.
Statistical analysis
Statistical analyses were performed using SPSS version
15.0 (SPSS Inc, Chicago, Ill). Shapiro-Wilk tests were
performed to assess normality of data. Mean ± standard
deviation was used to describe normally-distributed data
while median (interquartile range) was used to describe
non-parametric data. For normally-distributed data,
between-group (dengue, healthy control and non-dengue
febrile controls) and within-group (febrile, defervescence
and convalescence) differences were analyzed using one-
way ANOVA analyses with Bonferroni adjustment. For
non-parametric data, between-group and within-group
differences were analyzed using Kruskal-Wallis analyses
with Dunn’s adjustment. Spearman correlation analyses
Loke et al. Virology Journal 2013, 10:322 Page 8 of 9
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plasma LTB4 and serum hsCRP levels in dengue patients
and controls. Between group differences in in vitro stud-
ies were analysed using ANOVA with Bonferroni adjust-
ment for multiple comparisons. Statistical significance
was set at p < 0.05.
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